CDKN2A (Cyclin-Dependent Kinase Inhibitor 2A): CDKN2A is a tumour suppressor gene that produces two proteins, p16INK4A and p14ARF, which are involved in regulating the cell cycle and preventing tumour development. Mutations in CDKN2A are associated with an increased risk of several cancers, including melanoma and pancreatic cancer.